One Test’s Odyssey: Cancer Of Unknown Origin
In recent years Pathwork Diagnostics Inc. and Rosetta Genomics Ltd. have developed tests that use the molecular makeup of the cancer cells to provide insight on the cancer’s origin.
You may also be interested in...
There is a much-acknowledged urgency to ensure medtech products are certified as fast as possible, with fears persisting that delays will result in notified body bottlenecks and product shortages.
The diagnostics company has secured $10m from the foundation to develop a biomarker test for Parkinson’s disease.
Generics Bulletin previews the most noteworthy and anticipated events for December 2023.